Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Li, Xiangduan ^a   Geary, Greg G ^a   Gonzales, Rayna J ^a   Krause, Diana N ^a   Duckles, Sue P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclooxygenase 1; Endothelial nitric oxide synthase; Indomethacin; NG nitro L arginine methyl ester; Prostacyclin

Indexed keywords

CYCLOOXYGENASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD VESSEL FUNCTION; BRAIN ARTERY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DRUG TARGETING; ENZYME SYNTHESIS; ESTROGEN THERAPY; FEMALE; GENE DISRUPTION; LONG TERM CARE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD VESSELS; BODY WEIGHT; CEREBROVASCULAR CIRCULATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; EPOPROSTENOL; ESTROGENS; FEMALE; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OVARIECTOMY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; UTERUS; VASOCONSTRICTION;

EID: 3242686081     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01176.2003     Document Type: Article

References (46)

1. Barker JE, Bakhle YS, Anderson J, Treasure T, and Piper JP. Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br J Pharmacol 118: 6443-6448, 1996.
2. Beverelli F, Bea ML, Puybasset L, Giudicelli JF, and Berdeaux A. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform. Fundam Clin Pharmacol 11: 252-259, 1997.
3. Case J and Davison CA. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther 291: 524-530, 1999.
4. Chang WC, Nakao J, Orimo H, and Murota SI. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta 620: 472-482, 1980.
5. Curtis JF, Reddy NG, Mason RP, Kalyanaraman B, and Eling TE. Nitric oxide: a prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages. Arch Biochem Biophys 335: 369-376, 1996.
6. Davidge ST, Baker PN, Laughlin MK, and Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283, 1995.
7. De Wit C, Bolz SS, and Pohl U. Interaction of endothelial autacoids in microvascular control. Z Kardiol 89, Suppl 9: 113-116, 2000.
8. Doni MG, Whittle BJR, Palmer RMJ, and Moncada S. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 151: 19-25, 1988.
9. Geary GG, Krause DN, and Duckles SP. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol Heart Circ Physiol 275: H292-H300, 1998.
10. Geary GG, Krause DN, and Duckles SP. Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H511-H519, 2000.
11. Geary GG, McNeill AM, Ospina JA, Krause DN, and Duckles SP. Cerebrovascular NOS and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-α. J Appl Physiol 91: 2391-2399, 2001.
12. Hajdu MA and Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol Heart Circ Physiol 266: H1027-HI033, 1994.
13. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, and Chemtob S. A major role for prostacylin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 83: 721-729, 1998.
14. Hink U, Oelze M, Kolb P, Bachschmid M, Zou MH, Daiber A, Mollnau H, August M, Baldus S, Tsilimingas N, Walter U, Ullrich V, and Munzel T. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J Am Coll Cardiol 42: 1826-1834, 2003.
15. Huang A, Sun D, Shesely EG, Levee EM, Koller A, and Kaley G. Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am J Physiol Heart Circ Physiol 282: H429-H436, 2002.
16. Huang A, Wu Y, Sun D, Koller A, and Kaley G. Effect of estrogen on flow-induced dilation in NO deficiency: role of prostaglandins and EDHF. J Appl Physiol 91: 2561-2566, 2001.
17. Jun SS, Chen Z, Pace MC, and Shaul PW. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 102: 176-183, 1998.
18. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J, Shesely EG, and Harrison DG. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42: 206-213, 1999.
19. Kosonen O, Kankaanranta H, Malo-Ranta U, Ristimaki A, and Moilanen E. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Br J Pharmacol 125: 247-54, 1998.
20. Laemmel E, Bonnardel-Phu E, Hou X, Seror J, and Vicaut E. Interaction between nitric oxide and prostanoids in arterioles of rat cremaster muscle in vivo. Am J Physiol Heart Circ Physiol 285: H1254-H1260, 2003.
21. Lamping KG, Nuno DW, Shesely EG, Maeda N, and Faraci FM. Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol 279: H1906-H1912, 2000.
22. Marcelin-Jimenez G and Escalante B. Functional and cellular interactions between nitric oxide and prostacyclin. Comp Biochem Physiol C 129: 349-359, 2001.
23. Matthews JS, McWilliams PJ, Key BJ, and Keen M. Inhibition of prostacyclin release from cultured endothelial cells by nitrovascular drugs. Biochim Biophys Acta 1269: 237-242, 1995.
24. McNeill AM, Chang C, Stanczyk FZ, Duckles SP, and Krause DN. Estrogen increases endothelial nitric oxide synthase via an estrogen receptor in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685-1691, 2002.
25. McNeill AM, Kim N, Duckles SP, and Krause DN. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999.
26. Meng W, Ayata C, Waeber C, Huang PL, and Moskowitz MA. Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am J Physiol Heart Circ Physiol 274: H411-H415, 1998.
27. Meng W, Ma J, Ayata C, Hara H, Huang PL, Fishman MC, and Moskowitz MA. ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol Heart Circ Physiol 271: H1145-H1150, 1996.
28. Mikkola T, Ranta V, Orpana A, Ylirorkala O, and Viinkka L. Effect of physiological concentrations of estrogen on PG12 and NO in endothelial cells. Maturitas 25: 141-147, 1996.
29. New DI, Chesser AM, Thuraisingham RC, and Yaqoob MM. Cerebral artery responses to pressure and flow in uremic hypertensive and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 284: H1212-H1216, 2003.
30. Ortiz PA and Garvin JL. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 284: R628-R638, 2003.
31. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, and Okumura K. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278: H233-H238, 2000.
32. Ospina JA, Duckles SP, and Krause DN. 17β-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 285: H241-H250, 2003.
33. Ospina JA, Krause DN, and Duckles SP. 17β-Estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33: 600-605, 2002.
34. Puybasset L, Bea ML, Ghaleh B, Giudicelli JF, and Berdeaux A. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res 79: 343-357, 1996.
35. Rupnow HL, Phernetton TM, Modrick ML, Wiltbank MC, Bird IM, and Magness RR. Endothelial vasodilator productionby uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1, and PGIS protein expression. Biol Reprod 66: 468-474, 2002.
36. Salvemini D, Currie MG, and Mollace V. Nitric oxide-mediated cyclo-oxygenase activation: a key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 7: 2562-2568, 1996.
37. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996.
38. Steudel W, Ichinose F, Huang PL, Hurford WE, Jones RC, Bevan JA, Fishman MC, and Zapol WM. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81: 34-41, 1997.
39. Stirone C, Chu Y, Sunday L, Duckles SP, and Krause DN. 17β-Estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol 478: 35-38, 2003.
40. Stirone C, Duckles SP, and Krause DN. Multiple forms of estrogen receptor-α in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab 284: E184-E192, 2003.
41. Sun D, Huang A, Smith CJ, Stackpole CJ, Connetta JA, Shesely EG, Koller A, and Kaley G. Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 85: 288-293, 1999.
42. Thompson J and Khalil RA. Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol 30: 1-15, 2003.
43. Tsai AL, Wei C, and Kulmacz RJ. Interaction between nitric oxide and prostaglandin H synthase. Arch Biochem Biophys 313: 367-372, 1994.
44. Wade ML and Fitzpatrick FA. Nitric oxide modulates the activity of the hemoproteins prostaglandin 12 synthase and thromboxane A2 synthase. Arch Biochem Biophys 347: 174-180, 1997.
45. Wang W and Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 233: 748-751, 1997.
46. Xu HL, Santizo RA, Baughman VL, and Pelligrino DA. Nascent EDHF-mediated cerebral vasodilation in ovariectomized rats is not induced by eNOS dysfunction. Am J Physiol Heart Circ Physiol 285: H2045-H2053, 2003.